New insights in the treatment of radioiodine refractory differentiated thyroid carcinomas : to lenvatinib and beyond
A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting
Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes
Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro
Transport of treosulfan and temozolomide across an in-vitro blood–brain barrier model
All-trans retinoic acid suppresses topoisomerase IIα through the proteasomal pathway
Discovery of novel androgen receptor antagonists : a hybrid approach of pharmacophore-based and docking-based virtual screening
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells
MDI 301 suppresses myeloid leukemia cell growth in vitro and in vivo without the toxicity associated with all-trans retinoic acid therapy
S-1 combined with cisplatin versus cisplatin alone for the treatment of advanced gastric cancer : a pilot randomized-controlled trial
Administration of chemotherapy in patients on dialysis
Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies
Prolonged remission of recurrent cervical carcinoma following paclitaxel and carboplatin chemotherapy with paclitaxel maintenance chemotherapy